Skip to main content
Equibles

STATE STREET CORP

Position in SGMT — Sagimet Biosciences Inc.

CIK 93751 BOSTON, MA
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$15,422,061
+$14,749,144 QoQ
Shares Held
1,995,092
+1449.1% QoQ
Ownership
3.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 122 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. SGMT ranks #175 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in SGMT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,422,061 1,995,092
2026-03-31 $672,917 128,788
2025-12-31 $694,936 117,388
2025-09-30 $757,947 110,488
2025-06-30 $760,476 99,800
2025-03-31 $325,348 99,800
2024-12-31 $378,450 84,100
2024-09-30 $150,134 54,200
2024-06-30 $185,364 54,200
2024-03-31 $1,535,767 283,352
2023-12-31 $437,133 80,652
2023-09-30 $269,068 30,576